Insider Trades33 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Sell | TARA | Jesse Shefferman | CEO and President | 461,374 | $2.80 | $230.4M | -47.57% | +38.05% | $1.3M | -0.65% | — | Sell Now |
| Jun 2, 2026 | Sell | TARA | William Conkling | Chief Commercial Officer | 6,008 | $4.34 | $230.4M | -47.57% | +38.05% | $26.1K | -7.91% | — | Sell Now |
| Apr 8, 2026 | Sell | TARA | Jacqueline Zummo | Chief R&D Officer | 1,134 | $5.40 | $230.4M | -47.57% | +38.05% | $6.1K | -1.18% | — | Sell Now |
| Apr 1, 2026 | Sell | TARA | Jacqueline Zummo | Chief R&D Officer | 22,598 | $5.26 | $230.4M | -47.57% | +38.05% | $118.9K | -19.06% | — | Sell Now |
| Jan 26, 2026 | Sell | TARA | Hannah Fry | VP, Controller | 1,457 | $6.67 | $230.4M | -47.57% | +38.05% | $9.7K | -3.30% | — | Sell Now |
| Jan 26, 2026 | Sell | TARA | Patrick Fabbio | Chief Financial Officer | 3,261 | $6.67 | $230.4M | -47.57% | +38.05% | $21.8K | -4.84% | — | Sell Now |
| Jan 26, 2026 | Sell | TARA | Jacqueline Zummo | Chf Scientific Operations Off | 3,724 | $6.67 | $230.4M | -47.57% | +38.05% | $24.8K | -3.05% | — | Sell Now |
| Jan 26, 2026 | Sell | TARA | Jesse Shefferman | CEO and President | 8,732 | $6.67 | $230.4M | -47.57% | +38.05% | $58.2K | -0.85% | — | Sell Now |
| Jan 20, 2026 | Sell | TARA | Hannah Fry | VP, Controller | 2,132 | $5.60 | $230.4M | -47.57% | +38.05% | $11.9K | -4.60% | — | Sell Now |
| Jan 20, 2026 | Sell | TARA | Patrick Fabbio | Chief Financial Officer | 3,063 | $5.60 | $230.4M | -47.57% | +38.05% | $17.2K | -4.35% | — | Sell Now |
| Jan 20, 2026 | Sell | TARA | Jacqueline Zummo | Chf Scientific Operations Off | 6,578 | $5.60 | $230.4M | -47.57% | +38.05% | $36.8K | -5.10% | — | Sell Now |
| Jan 20, 2026 | Sell | TARA | Jesse Shefferman | CEO and President | 16,322 | $5.60 | $230.4M | -47.57% | +38.05% | $91.4K | -1.56% | — | Sell Now |
| Jun 26, 2025 | Sell | TARA | Jesse Shefferman | CEO and President | 18,667 | $2.98 | $230.4M | -47.57% | +38.05% | $55.6K | -0.48% | — | Sell Now |
| Jun 24, 2025 | Sell | TARA | Jesse Shefferman | CEO and President | 300,000 | $3.06 | $230.4M | -47.57% | +38.05% | $918.0K | -31.25% | — | Sell Now |
| Mar 26, 2025 | Sell | TARA | Jacqueline Zummo | Chf Scientific Operations Off | 21,224 | $4.53 | $230.4M | -47.57% | +38.05% | $96.1K | -17.67% | — | Sell Now |
| Jan 21, 2025 | Sell | TARA | Hannah Fry | VP, Controller | 2,130 | $4.76 | $230.4M | -47.57% | +38.05% | $10.1K | -7.23% | — | Sell Now |
| Jan 21, 2025 | Sell | TARA | Patrick Fabbio | Chief Financial Officer | 3,061 | $4.76 | $230.4M | -47.57% | +38.05% | $14.6K | -13.91% | — | Sell Now |
| Jan 21, 2025 | Sell | TARA | Jacqueline Zummo | Chf Scientific Operations Off | 6,554 | $4.76 | $230.4M | -47.57% | +38.05% | $31.2K | -6.42% | — | Sell Now |
| Jan 21, 2025 | Sell | TARA | Jesse Shefferman | CEO and President | 15,469 | $4.76 | $230.4M | -47.57% | +38.05% | $73.6K | -1.67% | — | Sell Now |
| Jan 3, 2025 | Sell | TARA | Hannah Fry | VP, Controller | 394 | $6.14 | $230.4M | -47.57% | +38.05% | $2.4K | -1.32% | — | Sell Now |
| Jan 3, 2025 | Sell | TARA | Jacqueline Zummo | Chf Scientific Operations Off | 2,157 | $6.14 | $230.4M | -47.57% | +38.05% | $13.2K | -2.07% | — | Sell Now |
| Jan 3, 2025 | Sell | TARA | Jesse Shefferman | CEO and President | 6,479 | $6.14 | $230.4M | -47.57% | +38.05% | $39.8K | -0.69% | — | Sell Now |
| Aug 28, 2024 | Sell | TARA | Jesse Shefferman | CEO and President | 8,563 | $1.99 | $230.4M | -47.57% | +38.05% | $17.0K | -0.45% | — | Sell Now |
| Jan 19, 2024 | Sell | TARA | Hannah Fry | VP, Controller | 904 | $1.91 | $230.4M | -47.57% | +38.05% | $1.7K | -1.18% | — | Sell Now |
| Jan 19, 2024 | Sell | TARA | Jathin Bandari | Chief Medical Officer | 2,879 | $1.91 | $230.4M | -47.57% | +38.05% | $5.5K | -1.46% | — | Sell Now |
| Jan 19, 2024 | Sell | TARA | Jacqueline Zummo | Chf Scientific Operations Off | 3,049 | $1.91 | $230.4M | -47.57% | +38.05% | $5.8K | -1.25% | — | Sell Now |
| Jan 19, 2024 | Sell | TARA | Jesse Shefferman | CEO and President | 7,803 | $1.91 | $230.4M | -47.57% | +38.05% | $14.9K | -0.60% | — | Sell Now |
| Jan 10, 2024 | Sell | TARA | Jathin Bandari | Chief Medical Officer | 1,877 | $2.39 | $230.4M | -47.57% | +38.05% | $4.5K | -4.88% | — | Sell Now |
| Jan 10, 2024 | Sell | TARA | Jacqueline Zummo | Chf Scientific Operations Off | 5,229 | $2.39 | $230.4M | -47.57% | +38.05% | $12.5K | -5.84% | — | Sell Now |
| Jan 10, 2024 | Sell | TARA | Jesse Shefferman | CEO and President | 5,746 | $2.39 | $230.4M | -47.57% | +38.05% | $13.7K | -0.64% | — | Sell Now |
| Jan 3, 2024 | Sell | TARA | Hannah Fry | VP, Controller | 324 | $2.17 | $230.4M | -47.57% | +38.05% | $703.08 | -1.40% | — | Sell Now |
| Jan 3, 2024 | Sell | TARA | Jacqueline Zummo | Chf Scientific Operations Off | 1,899 | $2.17 | $230.4M | -47.57% | +38.05% | $4.1K | -2.08% | — | Sell Now |
| Jan 3, 2024 | Sell | TARA | Jesse Shefferman | CEO and President | 5,840 | $2.17 | $230.4M | -47.57% | +38.05% | $12.7K | -0.65% | — | Sell Now |